Document is current

Article History

Accepted: 22 November 2024

First Online: 12 December 2024

Declarations

:

: Human cells and animal experiments were involved in this study. The use of the cells for the purpose of scientific research in our laboratory was approved by Ministry of Education and Research of French Republic in compliance with regulatory procedures that apply (DC 2013-1998, DC 2018-3143 and DC 2019-3713). Concerning the animal studies, upon a favorable opinion of the Bordeaux Ethics Committee for animal experimentation, this project was authorized by the French National Ministry of the High Education and Research (APAFIS#13468-2018020914295792v4).

: Not applicable in terms of clinical trial. The informed consent for the experimental use cells destined to be discarded was obtained systematically in context of the file for above-mentioned approvals of Ministry of Education and Research.

: All authors are aware of the manuscript content and did not present any objection concerning the publication of the manuscript.

: The SEC medium was patented by ZI, JC, LR, EA (FR 1558409; EP 16777718.4; US 15/580,699; CA 2,986,267). The cord blood collection procedure utilizing a special kit and HP02 medium was patented by B. Delorme and ZI under the title “Method for Preserving Placental Blood” (WO 2014/057220A1, International Publication Number).EA is currently employed by Institute Genethon (Evry, France). The authors (ZI, JC, LR, EA) declare no other commercial, proprietary, or financial interests in the products or companies discussed in this article. PD has been excluded from the list of patent inventors and declares no conflicts of interest.